J3 is a valid 2023 HCPCS Modifier that could be used to indicate Competitive acquisition program (cap), drug not available through cap as written, reimbursed under average sales price methodology.
J3 Modifier has been in effect since Jan 01, 2006.
Short description for J3 HCPCS Modifier code:
Cap drug unavail thru cap